KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $328.5 million.

  • Idexx Laboratories' Operating Expenses rose 1244.65% to $328.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1717.47%. This contributed to the annual value of $1.3 billion for FY2024, which is 1443.47% up from last year.
  • As of Q3 2025, Idexx Laboratories' Operating Expenses stood at $328.5 million, which was up 1244.65% from $321.7 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Operating Expenses peaked at $355.4 million during Q2 2024, and registered a low of $108.3 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $137.0 million (2023), whereas its average is $199.3 million.
  • Per our database at Business Quant, Idexx Laboratories' Operating Expenses crashed by 3347.92% in 2023 and then soared by 16095.88% in 2024.
  • Quarter analysis of 5 years shows Idexx Laboratories' Operating Expenses stood at $128.8 million in 2021, then fell by 1.79% to $126.5 million in 2022, then grew by 9.78% to $138.8 million in 2023, then surged by 122.55% to $309.0 million in 2024, then grew by 6.32% to $328.5 million in 2025.
  • Its last three reported values are $328.5 million in Q3 2025, $321.7 million for Q2 2025, and $306.8 million during Q1 2025.